1IA
NVO

1834 Investment Advisors’s Novo Nordisk NVO Stock Holding History

1834 Investment Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$821K Buy
17,129
+2,526
+17% +$109K 0.09% 134
2026
Q1 		$537K Buy
+14,603
New +$692K 0.07% 154
2024
Q1 		– Sell
-2,800
Closed -$290K – 226
2023
Q4 		$290K Hold
2,800
– – 0.03% 201
2023
Q3 		$255K Buy
+2,800
New +$247K 0.03% 210

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

1834 Investment Advisors's NVO Position: Q2 2026 in Review

1834 Investment Advisors increased its Novo Nordisk (NVO) stake by 17% in Q2 2026, buying an estimated $109K and bringing the position to 17,129 shares worth $821K. The position accounts for 0.09% of the portfolio, ranked #134.

1834 Investment Advisors first reported a position in NVO in Q3 2023 and has held it in 4 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • 1834 Investment Advisors held 17,129 shares of Novo Nordisk worth $821K as of Q2 2026.
  • 1834 Investment Advisors bought 2,526 Novo Nordisk shares in Q2 2026, an estimated $109K.
  • Novo Nordisk made up 0.09% of 1834 Investment Advisors's portfolio in Q2 2026, its #134 holding.
  • 1834 Investment Advisors first reported a position in Novo Nordisk in Q3 2023 and has held it in 4 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on 1834 Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.